Drug approvals

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

What is Wegovy prescribed for?   Wegovy (generic name: semaglutide), pronounced “weh-Go-veeh,” is an injectable prescription medication for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems, to help them lose weight and keep it off. What is the name of the drug and what does it do?  The...

Exciting New Drug Approval: WINREVAIR: March 26, 2024

Exciting New Drug Approval: WINREVAIR: March 26, 2024

What is WINREVAIR prescribed for?  WINREVAIR is prescribed to treat adults with pulmonary arterial hypertension. What is the name of the drug and what does it do? WINREVAIR pronounced WIN-reh-vair, (generic name: sotatercept-csrk) is used to treat adults with pulmonary arterial hypertension (PAH), a condition where there is high blood pressure in the arteries...

FDA Approves Jaypirca for Mantle Cell Lymphoma Treatment on January 20, 2023

FDA Approves Jaypirca for Mantle Cell Lymphoma Treatment on January 20, 2023

What is Jaypirca prescribed for?   Jaypirca is prescribed to treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor.  What is the name of the drug and what does it do? The name of the drug is Jaypirca, pronounced JAY-PIHR-KAA, (generic name: pirtobrutinib). It is a...

A New Era in Lung Cancer Treatment: FDA Approves Augtyro on November 15, 2023

A New Era in Lung Cancer Treatment: FDA Approves Augtyro on November 15, 2023

What is Augtyro prescribed for?  Augtyro is prescribed for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer. What is Augtyro and what does it do? Augtyro, pronounced Aug-TYE-ro, (generic name: repotrectinib) is a newly FDA-approved medication for treating a specific type of lung cancer called...